Navigation Links
Noninvasive Glaucoma Test Might Speed Up Detection
Date:12/1/2010

WEDNESDAY, Dec. 1 (HealthDay News) -- A test that measures the function of nerve cells in the retina may detect glaucoma at an early stage and help doctors evaluate the effectiveness of treatments, a new study has found.

Diagnosing glaucoma as early as possible -- before it destroys the optic nerve -- is key to preventing vision loss, according to the researchers, from the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine.

The test, known as a pattern electroretinogram optimized for glaucoma screening, measures the electrical activity of the retina as a person looks at an alternating pattern of black and white lines.

The test can detect dysfunction and abnormal changes in retinal ganglion cells (RGCs) that appear early in the glaucoma process, the researchers said, making it potentially valuable as a non-invasive method of detection.

Studying 47 people with glaucoma who had surgery because their intraocular pressure could not be controlled by medications, the researchers said the test was able to show reversal of RGC dysfunction and reduced intraocular pressure after the operations.

However, larger studies are needed to confirm the results, study co-leader Mitra Sehi said in a news release from the American Academy of Ophthalmology.

More information

The U.S. National Eye Institute has more about glaucoma.

SOURCE: American Academy of Ophthalmology, news release, Dec. 1, 2010

-- Robert Preidt

SOURCE: American Academy of Ophthalmology, news release, Dec. 1, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. New research shows innovative respiratory stress test can quickly detect significant coronary artery disease in a noninvasive setting
2. Noninvasive combination technique may reduce number of breast biopsies
3. Prediction tool helps estimate local recurrence in patients with noninvasive breast cancer
4. Noninvasive Test for Colon Cancer Shows Promise in Early Trial
5. Noninvasive brain stimulation helps improve motor function in stroke patients
6. Glaucoma Begins in Mid-Brain, Not in Eye, Research Shows
7. Waiting Safe for Some at Risk of Glaucoma
8. New Contact Lenses Could Improve Glaucoma Treatment
9. Glaucoma Cases on the Rise in U.S.
10. St. Michaels doctor wins $50,000 N.Y. Academy of Medicine Glaucoma Prize
11. Excess Weight May Protect Women From Type of Glaucoma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Noninvasive Glaucoma Test Might Speed Up Detection
(Date:1/18/2017)... ... , ... At Hallmark Nameplate, their commitment to quality is what sets them ... 13485. This certification is another way they are making constant strides to provide all ... need. , The ISO 13485 Certification is a major accomplishment for Hallmark Nameplate and ...
(Date:1/18/2017)... ... January 18, 2017 , ... Michael J. Hennessy ... for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. President Michael ... field of biosimilars through thought leader interaction in, live video and interactive digital ...
(Date:1/18/2017)... ... 18, 2017 , ... During pregnancy, women are at an ... those dental problems can increase the risk of pregnancy complications. Unfortunately, according to ... to get the dental care they need. Agoura Hills dentist, Philip Shindler ...
(Date:1/17/2017)... , ... January 17, 2017 , ... Anesthesia Progress ... for dentists to choose the best drug option for each patient. Dentists have several ... and better overall outcomes. , Researchers from the Tokyo Dental College in Tokyo, Japan ...
(Date:1/17/2017)... ... 17, 2017 , ... For breast cancer clinicians and researchers who were unable ... a more intimate review and analysis of its highlights, a novel half-day, complimentary meeting—the ... by Imedex on February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017  Dermata Therapeutics, LLC, ... to treat a variety of dermatological diseases, announces ... DMT210, in a Phase 2 acne rosacea study. ... downregulate the proinflammatory cytokines in the skin responsible ... rosacea. This clinical trial, DMT210-003, ...
(Date:1/18/2017)... Safe Rx LLC and Good Day Pharmacy, ... Loveland, Colorado , today announced the availability ... Day locations.     "Patients with prescriptions prone ... storage," said Milton Cohen , President & CEO ... a cup of coffee, you can protect your children ...
(Date:1/18/2017)... In China , we say Health is ... China,s Healthy Strategy originates. 2016 is ... and Social Development of the People,s Republic of ... council of the People,s Republic of China ... plan, identifying medical devices as one of the main breakthrough ...
Breaking Medicine Technology: